(Q54583340)

1 June 2018

title

Cell signaling. New mTOR targets Grb attention. (English)

1 reference

1 June 2018

1 reference

Sung Su Yea

1

1 reference

1 June 2018

David A Fruman

series ordinal

2

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 June 2011

1 reference

1 June 2018

number of pages

2

1 reference

based on heuristic

inferred from page(s)

published in

Science

1 reference

1 June 2018

volume

332

1 reference

1 June 2018

page(s)

1270-1271

1 reference

1 June 2018

issue

6035

1 reference

1 June 2018

mTOR: from growth signal integration to cancer, diabetes and ageing

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1208071

The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1208071

Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1208071

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1208071

Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1208071

Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1208071

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1208071

1 reference

1 June 2018

PubMed ID

21659593

1 reference

1 June 2018